| Trends of congestive heart failure epidemiology: contrast with clinical trial results. | |
| | |
MedLine Citation:
|
PMID: 10609389 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Congestive heart failure (CHF) is an important and growing public health problem and the cause of substantial morbidity and mortality. Its increasing incidence and prevalence may be in part explained by the progressive aging of the world population. The improvement in coronary artery disease and hypertension treatment allows the individuals to lie longer and develop CHF. Indeed, the most common etiology of CHF is coronary artery disease, the leading cause of cardiovascular morbidity and mortality worldwide, and the second cause of CHF is hypertension which is still markedly increasing in developing countries. Estimates of prevalence of CHF are 0.4 to 2% of the general population. The number of hospital admissions for CHF has also been steadily increasing. Half of the patients carrying a diagnosis of CHF will die within 4 years and patients with severe CHF will die within 1 year. At present, there is no evidence that the prognosis of heart failure in the community has changed despite the advances in therapy over the past decades, such as the demonstration that angiotensin-converting enzyme inhibitors and other vasodilators improve the clinical signs and symptoms of patients with CHF, reduce mortality and slow the progression of myocardial dysfunction. Nevertheless, the overall mortality from this condition remains very high. It is possible that the results of the trials have not yet been evidenced in the majority of patients with CHF because the ideal conditions, treatment and follow-up in the trials are not yet widely achieved in the population. |
| | |
Authors:
|
L J Dominguez; G Parrinello; P Amato; G Licata |
Related Documents
:
|
2152859 - Digitalis: a drug that refuses to die. 16937029 - Diagnosis of heart failure in primary care. 16863479 - Management of acute decompensated heart failure: treatment, controversy, and future dir... 8668609 - Evolving concepts in the treatment of heart failure: should new inotropic agents carry ... 9550589 - The treatment of heart failure: the role of neurohumoral activation. 9894619 - Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery dis... 1751179 - Recovery of end-stage organ dysfunction by circulatory assist. 20236669 - Exacerbation of systemic inflammation and increased cerebral infarct volume with cardio... 12718479 - Early and late outcome of stenting in a consecutive series of patients with coronary le... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiologia (Rome, Italy) Volume: 44 ISSN: 0393-1978 ISO Abbreviation: Cardiologia Publication Date: 1999 Sep |
Date Detail:
|
Created Date: 2000-01-14 Completed Date: 2000-01-14 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8506637 Medline TA: Cardiologia Country: ITALY |
Other Details:
|
Languages: eng Pagination: 801-8 Citation Subset: IM |
Affiliation:
|
Istituto di Clinica Medica, Università degli Studi, Palermo. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Clinical Trials as Topic Female Heart Failure / drug therapy, epidemiology* Humans Incidence Male Middle Aged Morbidity / trends Prevalence Survival Rate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The alternative "ischemic" cascade in coronary microvascular disease.
Next Document: Correlation of 99mTc-sestamibi SPECT myocardial perfusion imaging with absolute coronary flow reserv...